Nu-Med Plus, Inc.

NUMD

US67021R1041

Medical Equipment, Supplies & Distribution

Delayed OTC Markets Other stock markets 01:00:17 2024-04-29 pm EDT			5-day change	1st Jan Change
0.055 ^USD	+10.00%		-17.29%	+35.80%

Mar. 26	Nu-Med Plus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Nu-Med Plus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

NU-MED PLUS, INC. : Change in Directors or Principal Officers (form 8-K)

October 21, 2022 at 04:08 pm EDT

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 18, 2022, the Board of Directors recognized the need for an additional member of the Board of Directors, and unanimously consented to appoint Jeffrey L. Robins to the Board of Director.

Latest news about Nu-Med Plus, Inc.

Nu-Med Plus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26	CI
Nu-Med Plus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 01	CI
Nu-Med Plus, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
Nu-Med Plus, Inc. entered into a letter of intent to acquire Your Space, Inc.	23-05-14	CI
Nu-Med Plus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
Nu-Med Plus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-29	CI
Nu-Med Plus, Inc. Auditor Raises 'Going Concern' Doubt	23-03-28	CI
Nu-Med Plus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-21	CI
Nu-Med Plus, Inc. announced that it has received $0.1 million in funding from Your Space, Inc	22-11-17	CI
Nu-Med Plus, Inc. Appoints Jeffrey L. Robins to the Board of Director	22-10-21	CI
Nu-Med Plus, Inc. Announces Management Changes	22-09-13	CI
Nu-Med Plus, Inc. Announces Management Changes	22-09-13	CI
Nu-Med Plus, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
Nu-Med Plus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Nu-Med Plus, Inc. Auditor Raises 'Going Concern' Doubt	22-04-10	CI
Nu-Med Plus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-31	CI
Nu-Med Plus, Inc. Announces Executive Changes	22-01-04	CI
Nu-Med Plus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
Nu-Med Plus, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-16	CI
Nu-Med Plus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-17	CI
Nu-Med Plus, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-16	CI
Nu-Med Plus, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-19	CI
Nu-Med Plus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-14	CI
Nu-Med Plus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-30	CI
Nu-Med Plus, Inc. Announces Update on Two New Clinical Trials	20-03-25	CI

Nu-Med Plus, Inc. is a medical device company, which is principally engaged in the designing, development, enhancement and commercialization of later-stage medical devices. The Company is focused on the creation of a nitric oxide generating formulation, a hospital bedside nitric oxide (NO) delivery system, a clinical unit for use in medical clinics and rehabilitation centers and a mobile rechargeable device to deliver nitric oxide gas to offer solutions to hospitals, health systems and the medical community throughout the world. Hospital NO Unit delivers a continuous intra-breath concentration of therapeutic NO to patients who are on a ventilator in a hospital setting. Clinical Delivery System is a simplified version of the hospital unit. Portable Delivery System delivers high purity NO to the patient at prescribed intervals for 24 hours per day at controlled doses by means of a nasal cannula or a face mask. Reagent Delivery provides a range of concentrations and flow rates of NO.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
NU-MED PLUS, INC.	+35.80%	4.18M
ABBOTT LABORATORIES	-2.89%	187B
MEDTRONIC PLC	-2.11%	106B
BECTON, DICKINSON AND COMPANY	-4.55%	66.9B
DEXCOM, INC.	+1.02%	49.45B
CENCORA, INC.	+16.72%	48B
HOYA CORPORATION	+4.06%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+3.45%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+0.75%	26.25B
TERUMO CORPORATION	+12.96%	24.62B